Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Kidney Neoplasms × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 17 INDUSTRY 5 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Somatostatinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Insulinoma 1 Immunoblastic Lymphadenopathy 1 Glucagonoma 1 Glioma 1

Interventions

Gene Expression Profiling 6 Polymerase Chain Reaction 4 Filgrastim 3 Doxorubicin 3 Reverse Transcriptase Polymerase Chain Reaction 2 Radiotherapy 2 Radiosurgery 2 Microarray Analysis 2 Interferon-alpha 2 Immunohistochemistry 2 Ifosfamide 2 Gemcitabine 2 Cytogenetic Analysis 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 Carboplatin 2 Amplified Fragment Length Polymorphism Analysis 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 siltuximab 1 aldesleukin 1 Vincristine 1 Traumeel S 1 Sunitinib 1 Spectrum Analysis 1 Sevoflurane 1 Propofol 1 Pluvicto 1 Paclitaxel 1 Nucleic Acid Amplification Techniques 1 Isotretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01120249 2025-09-16

S0931

SWOG Cancer Research Network

Phase 3 Completed

1,545 enrolled 15 charts

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡